A wise man once said, “if at first you don’t succeed, you’d better hope your rivals don’t either,” or something like that. Republicans in Congress had their chance to shine, but with the recent failure of the American Health Care Act, Democrats are looking to beat them to the punch by improving the existing Affordable Care Act. A coalition, led by Senator Al Franken, proposed a bill that would require transparency from drug companies in R&D cost, acquisitions, investments, and other areas that influence pricing, and that information would then be publicly available. If passed, this bill could make congressional Democrats the modern-day healthcare heroes. They would be good enough, smart enough, and “doggone it” people would like them. Apparently, Sen. Franken already knows that.